Alessandro Agnoli Lecture. Models of basal ganglia dysfunction: predictions and pitfalls.
Albin
R L
RL
Department of Neurology, University of Michigan, Ann Arbor, USA.
Kearney
J A
JA
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects; D018663:Adrenergic Agents / Q000009:adverse effects; D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism / Q000503:physiopathology*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000009:adverse effects; D016627:Oxidopamine / Q000009:adverse effects; D010302:Parkinson Disease, Secondary / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D011237:Predictive Value of Tests; D020531:Subthalamic Nucleus / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D018663:Adrenergic Agents; D015259:Dopamine Agents; D005680:gamma-Aminobutyric Acid; D016627:Oxidopamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine